The Gut Microbiome and Xenobiotics: Identifying Knowledge Gaps

Author:

Sutherland Vicki L1,McQueen Charlene A2,Mendrick Donna3,Gulezian Donna4,Cerniglia Carl5,Foley Steven5,Forry Sam6,Khare Sangeeta3,Liang Xue7,Manautou Jose E8,Tweedie Donald5,Young Howard9,Alekseyenko Alexander V10,Burns Frank11,Dietert Rod12,Wilson Alan13,Chen Connie14

Affiliation:

1. National Toxicology Program, National Institute of Environmental Health Sciences, Durham, North Carolina 27709

2. Department of Pharmacology and Toxicology, University of Arizona, Tucson, Arizona 85721

3. National Center for Toxicological Research, US Food and Drug Administration, Silver Spring, MD 20993

4. Taconic Biosciences, Rensselaer, New York 12144

5. Department of Pharmacokinetics, Pharmacodynamics and Drug Metabolism, Merck & Co., Inc., Kenilworth, New Jersey 07033

6. Biosystems and Biomaterials Division, National Institute of Standards and Technology, Gaithersburg, Maryland 20899

7. Merck Exploratory Science Center, Merck & Co., Inc., Cambridge, Massachusetts 02141

8. Department of Pharmaceutics, University of Connecticut, Storrs, Connecticut 06269

9. Laboratory of Cancer Immunometabolism, Center for Cancer Research, NCI Frederick, Frederick, Maryland 21702

10. Program for Human Microbiome Research, Biomedical Informatics Center, Department of Public Health Sciences, Department of Oral Health Sciences, Department of Healthcare Leadership & Management, Medical University of South Carolina, Charleston, South Carolina 29425

11. BioPrimate LLC, Newark, Delaware 19711

12. Department of Microbiology and Immunology, Cornell University, Ithaca, New York 14850

13. Department of Drug Metabolism, Pharmacokinetics, Toxicology and Pathology, Lexicon Pharmaceuticals, Houston, Texas 77381

14. Health and Environmental Sciences Institute, Washington, District of Columbia 20005

Abstract

Abstract There is an increasing awareness that the gut microbiome plays a critical role in human health and disease, but mechanistic insights are often lacking. In June 2018, the Health and Environmental Sciences Institute (HESI) held a workshop, “The Gut Microbiome: Markers of Human Health, Drug Efficacy and Xenobiotic Toxicity” (https://hesiglobal.org/event/the-gut-microbiome-workshop) to identify data gaps in determining how gut microbiome alterations may affect human health. Speakers and stakeholders from academia, government, and industry addressed multiple topics including the current science on the gut microbiome, endogenous and exogenous metabolites, biomarkers, and model systems. The workshop presentations and breakout group discussions formed the basis for identifying data gaps and research needs. Two critical issues that emerged were defining the microbial composition and function related to health and developing standards for models, methods and analysis in order to increase the ability to compare and replicate studies. A series of key recommendations were formulated to focus efforts to further understand host-microbiome interactions and the consequences of exposure to xenobiotics as well as identifying biomarkers of microbiome-associated disease and toxicity.

Funder

Health and Environmental Sciences Institute

NIH

Publisher

Oxford University Press (OUP)

Subject

Toxicology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3